Total planned funding: $231,847,359
Clear active filters
Implementing Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| South Africa | $61,228,486 |
| Uganda | $37,893,612 |
| Nigeria | $32,804,399 |
| Zimbabwe | $24,389,550 |
| Ethiopia | $17,949,027 |
| Côte d'Ivoire | $16,631,050 |
| Tanzania | $8,481,036 |
| Dominican Republic | $7,158,156 |
| Cameroon | $7,126,175 |
| Malawi | $4,125,385 |
| Guyana | $2,836,289 |
| Zambia | $2,750,903 |
| Kenya | $2,585,000 |
| Mozambique | $1,897,922 |
| Vietnam | $1,518,174 |
| Indonesia | $750,000 |
| Botswana | $616,000 |
| Caribbean Region | $422,000 |
| Lesotho | $407,364 |
| Ghana | $100,000 |
| Ukraine | $100,000 |
| Cambodia | $50,000 |
| Eswatini | $26,831 |
| Asia Regional Program | $0 |
| Namibia | $0 |
| Angola | $0 |
Organizational Types
| Implementing Agency | $231,847,359 |
Program Areas
| Care | $72,013,721 |
| Treatment | $61,334,369 |
| Prevention | $54,279,883 |
| Governance and Systems | $26,995,065 |
| Testing | $17,224,321 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $52,681,177 |
| HKID: Care: Orphans and Vulnerable Children | $31,782,809 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $24,429,145 |
| HBHC: Care: Adult Care and Support | $22,648,644 |
| HVCT: Testing: HIV Testing and Counseling | $17,224,321 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $15,755,614 |
| HVTB: Care: TB/HIV | $12,412,591 |
| HLAB: Laboratory Infrastructure | $10,993,984 |
| HVSI: Strategic Information | $8,946,328 |
| PDTX: Treatment: Pediatric Treatment | $8,653,192 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $8,274,430 |
| OHSS: Health Systems Strengthening | $7,054,753 |
| PDCS: Care: Pediatric Care and Support | $5,169,677 |
| HMBL: Biomedical Prevention: Blood Safety | $3,457,291 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,685,822 |
| HMIN: Biomedical Prevention: Injection Safety | $527,581 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $150,000 |
| HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
University of the Witwatersrand:
$26,071,160
View countries
Uganda Episcopal Conference:
$12,849,050
View countries